ANTICANCER FUSION PROTEIN
A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with th...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PIECZYKOLAN, JERZY SZCZEPAN ZEREK, BARTLOMIEJ MACIEJ PIECZYKOLAN, ANNA MARIA PAWLAK, SEBASTIAN SZYMANIK, MICHAL ROZGA, PIOTR JAWORSKI, ALBERT ROBERT TESKA-KAMINSKA, MALGORZATA IZABELA |
| description | A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and domain (b) which is a sequence of an effector peptide inhibiting protein synthesis, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HK1201727A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HK1201727A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HK1201727A13</originalsourceid><addsrcrecordid>eNrjZJB09AvxdHb0c3YNUnALDfb091MICPIPcfX042FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8R7ehkYGhuZG5o6GxkQoAQDcLR-Z</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICANCER FUSION PROTEIN</title><source>esp@cenet</source><creator>PIECZYKOLAN, JERZY SZCZEPAN ; ZEREK, BARTLOMIEJ MACIEJ ; PIECZYKOLAN, ANNA MARIA ; PAWLAK, SEBASTIAN ; SZYMANIK, MICHAL ; ROZGA, PIOTR ; JAWORSKI, ALBERT ROBERT ; TESKA-KAMINSKA, MALGORZATA IZABELA</creator><creatorcontrib>PIECZYKOLAN, JERZY SZCZEPAN ; ZEREK, BARTLOMIEJ MACIEJ ; PIECZYKOLAN, ANNA MARIA ; PAWLAK, SEBASTIAN ; SZYMANIK, MICHAL ; ROZGA, PIOTR ; JAWORSKI, ALBERT ROBERT ; TESKA-KAMINSKA, MALGORZATA IZABELA</creatorcontrib><description>A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and domain (b) which is a sequence of an effector peptide inhibiting protein synthesis, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150911&DB=EPODOC&CC=HK&NR=1201727A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150911&DB=EPODOC&CC=HK&NR=1201727A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PIECZYKOLAN, JERZY SZCZEPAN</creatorcontrib><creatorcontrib>ZEREK, BARTLOMIEJ MACIEJ</creatorcontrib><creatorcontrib>PIECZYKOLAN, ANNA MARIA</creatorcontrib><creatorcontrib>PAWLAK, SEBASTIAN</creatorcontrib><creatorcontrib>SZYMANIK, MICHAL</creatorcontrib><creatorcontrib>ROZGA, PIOTR</creatorcontrib><creatorcontrib>JAWORSKI, ALBERT ROBERT</creatorcontrib><creatorcontrib>TESKA-KAMINSKA, MALGORZATA IZABELA</creatorcontrib><title>ANTICANCER FUSION PROTEIN</title><description>A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and domain (b) which is a sequence of an effector peptide inhibiting protein synthesis, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB09AvxdHb0c3YNUnALDfb091MICPIPcfX042FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8R7ehkYGhuZG5o6GxkQoAQDcLR-Z</recordid><startdate>20150911</startdate><enddate>20150911</enddate><creator>PIECZYKOLAN, JERZY SZCZEPAN</creator><creator>ZEREK, BARTLOMIEJ MACIEJ</creator><creator>PIECZYKOLAN, ANNA MARIA</creator><creator>PAWLAK, SEBASTIAN</creator><creator>SZYMANIK, MICHAL</creator><creator>ROZGA, PIOTR</creator><creator>JAWORSKI, ALBERT ROBERT</creator><creator>TESKA-KAMINSKA, MALGORZATA IZABELA</creator><scope>EVB</scope></search><sort><creationdate>20150911</creationdate><title>ANTICANCER FUSION PROTEIN</title><author>PIECZYKOLAN, JERZY SZCZEPAN ; ZEREK, BARTLOMIEJ MACIEJ ; PIECZYKOLAN, ANNA MARIA ; PAWLAK, SEBASTIAN ; SZYMANIK, MICHAL ; ROZGA, PIOTR ; JAWORSKI, ALBERT ROBERT ; TESKA-KAMINSKA, MALGORZATA IZABELA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HK1201727A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2015</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>PIECZYKOLAN, JERZY SZCZEPAN</creatorcontrib><creatorcontrib>ZEREK, BARTLOMIEJ MACIEJ</creatorcontrib><creatorcontrib>PIECZYKOLAN, ANNA MARIA</creatorcontrib><creatorcontrib>PAWLAK, SEBASTIAN</creatorcontrib><creatorcontrib>SZYMANIK, MICHAL</creatorcontrib><creatorcontrib>ROZGA, PIOTR</creatorcontrib><creatorcontrib>JAWORSKI, ALBERT ROBERT</creatorcontrib><creatorcontrib>TESKA-KAMINSKA, MALGORZATA IZABELA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PIECZYKOLAN, JERZY SZCZEPAN</au><au>ZEREK, BARTLOMIEJ MACIEJ</au><au>PIECZYKOLAN, ANNA MARIA</au><au>PAWLAK, SEBASTIAN</au><au>SZYMANIK, MICHAL</au><au>ROZGA, PIOTR</au><au>JAWORSKI, ALBERT ROBERT</au><au>TESKA-KAMINSKA, MALGORZATA IZABELA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICANCER FUSION PROTEIN</title><date>2015-09-11</date><risdate>2015</risdate><abstract>A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and domain (b) which is a sequence of an effector peptide inhibiting protein synthesis, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_HK1201727A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | ANTICANCER FUSION PROTEIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A12%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PIECZYKOLAN,%20JERZY%20SZCZEPAN&rft.date=2015-09-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHK1201727A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |